Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Reimbursement, Sales Critical For IPOs As Markets Reopen To Device Firms

This article was originally published in The Gray Sheet

Executive Summary

"Reimbursement clarity" is essential for device firms in gaining investor confidence in the public equity market, Jeffrey Hoffman, health technology investment banker with U.S. Bancorp Piper Jaffray, emphasized at the recent Frost & Sullivan 5th Annual Medical Devices and Diagnostics Industry Conference in San Francisco.

You may also be interested in...



Conceptus Phase III STOP Trial Designed To Show Clinical And Cost Benefit

Conceptus intends to secure third-party reimbursement by examining cost-effectiveness endpoints as a part of Phase III pivotal studies of the firm's STOP non-surgical permanent female contraceptive device.

Conceptus Phase III STOP Trial Designed To Show Clinical And Cost Benefit

Conceptus intends to secure third-party reimbursement by examining cost-effectiveness endpoints as a part of Phase III pivotal studies of the firm's STOP non-surgical permanent female contraceptive device.

HCFA Officials Seek To Protect Local Coverage Review Flexibility

The ongoing reform of the Health Care Financing Administration's coverage review process should preserve the ability of Medicare carriers to develop local policy, according to HCFA Administrator Nancy-Ann DeParle.

Related Content

UsernamePublicRestriction

Register

MT013166

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel